Beyondspring Inc News Today

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ...

FLORHAM PARK, N.J., April 29, 2024 -- BeyondSpring Inc. , a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it has filed its...

Wild swings in Magnificent Seven stocks are once again acting as a driver of volatility across U.S. equities. Investors could face more turbulence this week as the Federal Reserve takes center... -April 29, 2024 at 06:23 am EDT - MarketScreener

29.04.2024 - FLORHAM PARK, N.J., April 29, 2024 (GLOBE NEWSWIRE) - BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a clinical-stage global biopharmaceutical company focused on developing innovative cancer therapies, today announced that it ...

The S&P 500 SPX is on pace for its biggest monthly drop since December 2022, with Aprils pullback erasing about half the gains the U.S. stock market had booked this year by the end of March. The... -April 22, 2024 at 06:22 am EDT - MarketScreener

BeyondSpring (NASDAQ:BYSI – Get Free Report) and Ovid Therapeutics (NASDAQ:OVID – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, earnings and institutional ownership. Institutional & Insider Ownership 40.3% of BeyondSpring shares […]

BeyondSpring (NASDAQ:BYSI – Get Free Report) and Ovid Therapeutics (NASDAQ:OVID – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, profitability, dividends, analyst recommendations and valuation. Risk & Volatility BeyondSpring has a beta of […]

NEW YORK, Jan. 10, 2024 -- BeyondSpring Inc. , a global clinical-stage biopharmaceutical company focused on using a groundbreaking technology platform for drug discovery and developing innovative...

NEW YORK, Jan. 10, 2024 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ: BYSI) (“BeyondSpring” or the “Company”), a global clinical-stage biopharmaceutical...

Dublin, Nov. 28, 2023 (GLOBE NEWSWIRE) -- The